PDRX
Price
$2.41
Change
-$0.34 (-12.36%)
Updated
Jun 5 closing price
Capitalization
N/A
SHPMY
Price
$8.00
Change
+$0.52 (+6.95%)
Updated
Jul 25 closing price
Capitalization
9.5B
Interact to see
Advertisement

PDRX vs SHPMY

Header iconPDRX vs SHPMY Comparison
Open Charts PDRX vs SHPMYBanner chart's image
PD-RX Pharmaceuticals
Price$2.41
Change-$0.34 (-12.36%)
Volume$5.59K
CapitalizationN/A
Shanghai Pharmaceuticals Holdings
Price$8.00
Change+$0.52 (+6.95%)
Volume$158
Capitalization9.5B
PDRX vs SHPMY Comparison Chart in %
Loading...
PDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDRX vs. SHPMY commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDRX is a Hold and SHPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (PDRX: $2.41 vs. SHPMY: $8.00)
Brand notoriety: PDRX and SHPMY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: PDRX: 125% vs. SHPMY: 38%
Market capitalization -- PDRX: $0 vs. SHPMY: $9.5B
PDRX [@Medical Distributors] is valued at $0. SHPMY’s [@Medical Distributors] market capitalization is $9.5B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDRX’s FA Score shows that 0 FA rating(s) are green whileSHPMY’s FA Score has 0 green FA rating(s).

  • PDRX’s FA Score: 0 green, 5 red.
  • SHPMY’s FA Score: 0 green, 5 red.
According to our system of comparison, SHPMY is a better buy in the long-term than PDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDRX’s TA Score shows that 2 TA indicator(s) are bullish while SHPMY’s TA Score has 2 bullish TA indicator(s).

  • PDRX’s TA Score: 2 bullish, 1 bearish.
  • SHPMY’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, PDRX is a better buy in the short-term than SHPMY.

Price Growth

PDRX (@Medical Distributors) experienced а 0.00% price change this week, while SHPMY (@Medical Distributors) price change was +9.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +3.49%. For the same industry, the average monthly price growth was +10.91%, and the average quarterly price growth was +3.82%.

Industries' Descriptions

@Medical Distributors (+3.49% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMY YTD gains are higher at: -1.350 vs. PDRX (-20.984).
PDRXSHPMYPDRX / SHPMY
CapitalizationN/A9.5B-
EBITDAN/A11.1B-
Gain YTD-20.984-1.3501,554%
P/E RatioN/A8.39-
RevenueN/A241B-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PDRX vs SHPMY: Fundamental Ratings
PDRX
SHPMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
10080
PRICE GROWTH RATING
1..100
8044
P/E GROWTH RATING
1..100
10069
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDRX's Valuation (41) in the null industry is in the same range as SHPMY (62). This means that PDRX’s stock grew similarly to SHPMY’s over the last 12 months.

SHPMY's Profit vs Risk Rating (80) in the null industry is in the same range as PDRX (100). This means that SHPMY’s stock grew similarly to PDRX’s over the last 12 months.

SHPMY's SMR Rating (80) in the null industry is in the same range as PDRX (100). This means that SHPMY’s stock grew similarly to PDRX’s over the last 12 months.

SHPMY's Price Growth Rating (44) in the null industry is somewhat better than the same rating for PDRX (80). This means that SHPMY’s stock grew somewhat faster than PDRX’s over the last 12 months.

SHPMY's P/E Growth Rating (69) in the null industry is in the same range as PDRX (100). This means that SHPMY’s stock grew similarly to PDRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDRXSHPMY
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
69%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
69%
Momentum
ODDS (%)
Bullish Trend 5 days ago
42%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
31%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
31%
Bullish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
27%
Bullish Trend 3 days ago
57%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
35%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRO16.350.65
+4.14%
Pros Holdings
ELAN14.920.23
+1.57%
Elanco Animal Health
SATL3.560.02
+0.56%
Satellogic Inc
MKTW20.30-0.19
-0.93%
MarketWise Inc
BTSGU72.59-0.85
-1.16%
BrightSpring Health Services

PDRX and

Correlation & Price change

A.I.dvisor tells us that PDRX and NSVGF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDRX and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDRX
1D Price
Change %
PDRX100%
N/A
NSVGF - PDRX
8%
Poorly correlated
N/A
SHPMY - PDRX
8%
Poorly correlated
+9.93%
SHPMF - PDRX
1%
Poorly correlated
N/A
ARRJF - PDRX
0%
Poorly correlated
N/A
MEPDF - PDRX
0%
Poorly correlated
N/A
More

SHPMY and

Correlation & Price change

A.I.dvisor tells us that SHPMY and PDRX have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMY and PDRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMY
1D Price
Change %
SHPMY100%
+9.93%
PDRX - SHPMY
8%
Poorly correlated
N/A
ZYXI - SHPMY
5%
Poorly correlated
+1.98%
NSVGF - SHPMY
4%
Poorly correlated
N/A
SHTDF - SHPMY
3%
Poorly correlated
N/A
MEPDF - SHPMY
-3%
Poorly correlated
N/A
More